| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO
2 companies
Pomerantz Roger is a President And CEO at Seres Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 56,789 | $29.81 | $1,692,704.72 | -8.5% | |
| Jun 2, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 74,049 | $32.52 | $2,407,915.67 | -10.4% | |
| Jun 1, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 70,951 | $30.51 | $2,164,837.85 | -14.5% | |
| May 24, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 9,801 | $30.00 | $294,030.00 | -5.1% | |
| May 6, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 8,507 | $24.31 | $206,802.52 | -15.7% | |
| May 5, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 59,325 | $26.13 | $1,550,277.92 | -39.5% | |
| May 3, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 67,367 | $28.70 | $1,933,196.89 | -34.2% | |
| Apr 7, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 9,212 | $30.00 | $276,360.00 | -28.8% | |
| Apr 4, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 135,788 | $27.20 | $3,693,795.49 | -34.3% |